Giulia Agliardi

690 total citations · 1 hit paper
10 papers, 432 citations indexed

About

Giulia Agliardi is a scholar working on Oncology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Giulia Agliardi has authored 10 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Biomedical Engineering. Recurrent topics in Giulia Agliardi's work include CAR-T cell therapy research (6 papers), MRI in cancer diagnosis (2 papers) and RNA Interference and Gene Delivery (2 papers). Giulia Agliardi is often cited by papers focused on CAR-T cell therapy research (6 papers), MRI in cancer diagnosis (2 papers) and RNA Interference and Gene Delivery (2 papers). Giulia Agliardi collaborates with scholars based in United Kingdom, Switzerland and India. Giulia Agliardi's co-authors include Mark F. Lythgoe, Rajiv Ramasawmy, Thomas A. Roberts, Alastair Hotblack, Martin Pulé, Cassandra Stowe, Tammy L. Kalber, Bernard Siow, Francesco Nannini and Burkhard Becher and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Giulia Agliardi

9 papers receiving 428 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma

2021 222 citations Giulia Agliardi, Anna Rita Liuzzi et al. Nature Communications profile →

Peers

Countries citing papers authored by Giulia Agliardi

Since Specialization

Citations

This map shows the geographic impact of Giulia Agliardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Agliardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Agliardi more than expected).

Fields of papers citing papers by Giulia Agliardi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Agliardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Agliardi. The network helps show where Giulia Agliardi may publish in the future.

Co-authorship network of co-authors of Giulia Agliardi

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Agliardi. A scholar is included among the top collaborators of Giulia Agliardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Agliardi. Giulia Agliardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival 2023 ·Journal for ImmunoTherapy of Cancer ·(unknown), Giulia Agliardi, Juliana Dias, Manar Shafat, (unknown), Louisa Green, Alastair Hotblack, (unknown), Karl S. Peggs, Anniek B. van der Waart, Harry Dolstra, Martin Pulé, Claire Roddie	16
2	A Compact and Simple Method of Achieving Differential Transgene Expression by Exploiting Translational Readthrough 2022 ·BioTechniques ·James Sillibourne, Giulia Agliardi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christopher Allen, (unknown), (unknown), Frederick Arce Vargas, Simon Thomas, Shaun Cordoba, Martin Pulé	1
3	Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma breakdown → 2021 ·Nature Communications ·Giulia Agliardi, Anna Rita Liuzzi, Alastair Hotblack, Donatella De Feo, Nicolás Gonzalo Núñez, Cassandra Stowe, Ekaterina Friebel, Francesco Nannini, Lukas Rindlisbacher, Thomas A. Roberts, Rajiv Ramasawmy, (unknown), Bernard Siow, Mark F. Lythgoe, Tammy L. Kalber, Sergio A. Quezada, Martin Pulé, Sònia Tugues, Karin Straathof, Burkhard Becher	222
4	Tunable control of CAR T cell activity through tetracycline mediated disruption of protein–protein interaction 2021 ·Scientific Reports ·Alastair Hotblack, Evangelia Kokalaki, (unknown), Gordon Weng-Kit Cheung, (unknown), (unknown), (unknown), Alice Piapi, Valeria Fiaccadori, Patrycja Wawrzyniecka, (unknown), Giulia Agliardi, Claire Roddie, Shimobi Onuoha, Simon Thomas, Shaun Cordoba, Martin Pulé	18
5	Noninvasive diffusion magnetic resonance imaging of brain tumour cell size for the early detection of therapeutic response 2020 ·Scientific Reports ·Thomas A. Roberts, Harpreet Hyare, Giulia Agliardi, (unknown), (unknown), Andrada Ianuș, (unknown), Rajiv Ramasawmy, Valerie H. Taylor, David Atkinson, Shonit Punwani, Mark F. Lythgoe, Bernard Siow, Sebastian Brandner, Jeremy Rees, Eleftheria Panagiotaki, Daniel C. Alexander, Simon Walker‐Samuel	40
6	Abstract 1070: AUTO7: Anti-PSMA humanized CAR T-cell with improved persistence and resistance to tumor microenvironment for metastatic castration resistant prostate cancer (mCRPC) 2020 ·Cancer Research ·Marco Della Peruta, (unknown), (unknown), Mathew Robson, Philip Fei Wu, (unknown), Mathieu Ferrari, Giulia Agliardi, James Sillibourne, Simon Thomas, Shimobi Onuoha, Shaun Cordoba, Martin Pulé	1
7	Near-infrared dual bioluminescence imaging in mouse models of cancer using infraluciferin 2019 ·eLife ·Cassandra Stowe, Thomas A. Burley, (unknown), Maria Vinci, Gabriela Krämer-Marek, (unknown), Gary N. Parkinson, Tara L. Southworth, Giulia Agliardi, Alastair Hotblack, Mark F. Lythgoe, Bruce R. Branchini, Tammy L. Kalber, James C. Anderson, Martin Pulé	47
8	Hampering Brain Tumor Proliferation and Migration Using Peptide Nanofiber:si PLK1 / MMP2 Complexes 2019 ·Nanomedicine ·Mariarosa Mazza, Hassan Ahmad, Marilena Hadjidemetriou, Giulia Agliardi, Omar Pathmanaban, Andrew T. King, Brian Bigger, Sandra Vranic, Kostas Kostarelos	9
9	Computational fluid dynamics with imaging of cleared tissue and of in vivo perfusion predicts drug uptake and treatment responses in tumours 2018 ·Nature Biomedical Engineering ·(unknown), Paul W. Sweeney, (unknown), (unknown), Rajiv Ramasawmy, Thomas A. Roberts, Giulia Agliardi, Adrien E. Desjardins, Mark F. Lythgoe, RB Pedley, Rebecca J. Shipley, Simon Walker‐Samuel	77
10	CAR T Cells Combined With PD1 Blockade Promote Long-Term Efficacy in a Mouse Model for High Grade Gliomas 2017 ·UCL Discovery (University College London) ·Giulia Agliardi, Ankit Patel, Adriana Romiti, Tammy L. Kalber, Thomas A. Roberts, (unknown), Mark P. Lythgoe, Jaime Anderson, (unknown), Martin Pulé, Karin Straathof	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact